Meet an Unreasonable Venture
Epoch Biodesign
Using AI-designed enzymes to enable infinite recycling of mixed plastics and textiles.
Epoch Biodesign develops enzymatic processes to recycle plastic and textile waste, starting with nylon. Using AI-driven synthetic biology and materials science, it breaks plastics down into high-purity chemical building blocks for reuse. Based in London, Epoch operates at lab scale, with a demo facility targeting 150 metric tonnes annually in 2025. Long term, it aims to license and operate its technology globally, driving scalable circularity.
Notable Achievements
- Raised more than $50M from investors including Lowercarbon Capital, Inditex, and Extantia.
- Working with over 30 leading brands to develop and scale circular textile solutions.
- Built a world-class team of 30 biochemists, process engineers, and ML scientists.
Currently Operating in One Region
Work at Epoch Biodesign
More Ventures in Energy & Environment
Get the Unreasonable Newsletter
Get monthly updates on Epoch Biodesign and all of the other ventures working to solve the world's toughest problems.